FDA Grants Breakthrough Device Designation to Anumana's ECG

Developed in collaboration with Janssen and Mayo Clinic, this technology has the potential to aid physicians in earlier detection of pulmonary hypertension, a progressive, life-threatening disease

Related Keywords

Australia , New Zealand , United Kingdom , Australian , Venky Soundararajan , Paul Friedman , Respirol Carlton Vic , Najat Khan , Us Food Drug Administration , Prevalence Of World Health Organization Groups , Electronic Health Record , Janssen Research Development , Anumana Inc , Department Of Cardiovascular Medicine At Mayo Clinic , Drug Administration , Breakthrough Device Designation , Pulmonary Hypertension , Early Detection , Device Designation , Chief Scientific Officer , Detection Algorithm , Janssen Research , Mayo Clinic Platform , Medical Device , Management System , Chief Data Science Officer , Global Head , Cardiovascular Medicine , Pulmonary Hypertension Early Detection Algorithm , Mayo Clinic , Emergency Use Authorization , Nature Medicinein , World Health Organization Groups , Circ Cardiovasc Qual , Intern Med , Eur Respir ,